Ritumax (rituximab biosimilar) / ChemRar - LARVOL DELTA

EULAR 2022 – Day 3 Report (RheumNow) - "By now, those of us attending the meeting know how to find a free coffee or sprite, have found comfortable meeting nooks and know our way around (lots of sneaker mileage)! And congrats to you virtual Rheums for mastering the multi-screen, multitask simultaneous consumption posters, tweets and oral abstract presentations! Power on; there's one more day."

Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera® (clinicaltrials.gov) - P1; N=8; Terminated; Sponsor: Biointegrator LLC; N=120 ➔ 8; Recruiting ➔ Terminated; Sponsor's decision

Clinical • Enrollment change • Trial termination